SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BD35C0B25BE50AE15F7AF126129B72F67CC662EE8ED34DC828024DF2BCDA41C3DFDD57DE10CEBE8A127870E58F149598>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BD35C0B25BE50AE15F7AF126129B72F67CC662EE8ED34DC828024DF2BCDA41C3DFDD57DE10CEBE8A127870E58F149598
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BD35C0B25BE50AE15F7AF126129B72F67CC662EE8ED34DC828024DF2BCDA41C3DFDD57DE10CEBE8A127870E58F149598
http://www.w3.org/2000/01/rdf-schema#comment
"No genetic marker clearly indicative of disease susceptibility or resistance was identified in this study. However HLA-DRB1*14 was more frequent in TB patients"
xsd:string
http://purl.uniprot.org/uniprot/#_145334F5EC698F348261E6B5E62FBA8D002B476FD78ED0C49B790FBC3D710DD7C445AB293A8D321644A9B7096C43064E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BD35C0B25BE50AE15F7AF126129B72F67CC662EE8ED34DC828024DF2BCDA41C3DFDD57DE10CEBE8A127870E58F149598
http://purl.uniprot.org/uniprot/I2G7Y6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BD35C0B25BE50AE15F7AF126129B72F67CC662EE8ED34DC828024DF2BCDA41C3DFDD57DE10CEBE8A127870E58F149598
http://purl.uniprot.org/uniprot/#_I2G7Y6-mappedCitation-21251479
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BD35C0B25BE50AE15F7AF126129B72F67CC662EE8ED34DC828024DF2BCDA41C3DFDD57DE10CEBE8A127870E58F149598